Ask VialBase
healing

PEG-MGF

FDA: research-only

PEG-MGF is a PEGylated splice variant of IGF-1 that activates satellite cells in muscle tissue. The PEGylation extends its half-life, enhancing systemic recovery effects post-exercise and making it effective for muscle atrophy reversal and tissue regeneration. Splice variant of IGF-1 that activates satellite cells in muscle tissue. PEGylation extends its half-life for better systemic distribution compared to native MGF. Kickstarts muscle regrowth during and after immobilization. Promotes muscle repair and hypertrophy through satellite cell activation. - Muscle atrophy reversal - Muscle mass recovery post-immobilization - Post-exercise recovery enhancement - Satellite cell activation - Tissue regeneration support - Standard: 200 mcg

This content is for educational and research purposes only. VialBase does not provide medical advice. Consult a healthcare professional before using any peptide.

Molecular weight —
Half-life —
CAS number —
Route —
02

Sourcing

Current prices

Updated today

5mg

Only vendor stocking this size on the VialBase roster.

Stocks this compound Third-party tested Public COAs Positive rep

Save 15% with code VIALBASE at checkout

VialBase may earn a commission on purchases through partner links — never at additional cost to you. Full disclosure.

Also vetted at
What bloodwork do I need?

Reference ranges are general guidelines. Consult your physician for interpretation.

PRE-CYCLE
  • IGF-1
  • CMP
  • CBC
  • Fasting Glucose
DURING CYCLE
  • IGF-1
  • Fasting Glucose
POST-CYCLE
  • IGF-1
  • CMP
Safety & Regulatory Status
FDA STATUS research-only

Regulatory status for PEG-MGF may change. Verify current status with your jurisdiction before use. This is not legal or medical advice.